Biosensors are prominent detection tools for evaluating various analytical markers. However, these devices that meet practical application scenarios are still limited, and their potential remains to be developed. In these aspects, we attempted to design and construct a synergistic amplifier consisting of two components, namely, a transcriptional activation component mediated by the Gal3 C regulator and a transcription recruitment component exploiting the function of dCas9-(SpyC) n, which work together to enhance yeast biosensor performance. This synergistic amplifier increased the signal output by 5.1-folds and the detection limit by 4.4-folds, respectively, while maintaining adjustable sensitivity and avoiding noise introduction during signal amplification. We demonstrated the use of synergistic amplifier in detecting dioxin analogues, aiming to unlock the potential of predictive modulation, and found that it achieved progress in dynamic output and detection limit. This work show that synergistic amplifier is a new paradigm for expanding signal processing pathways within synthetic genetic networks, enabling cell-based biosensors for environmental monitoring.
No takes yet. Share an insight, caveat, or question.
Du et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: